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The interaction of BKV with its natural target cells, human kidney epithelial cells, has not been studied. In vitro infections of human
primary kidney epithelial cells were performed to investigate a BKV infection in its natural host cell. BKV undergoes a lytic replication
cycle in this system: high levels of T antigen expression were first detected at 36 h postinfection, while viral DNA replication, capsid
protein expression, and progeny virus were observed at 48 h postinfection. It was observed that the related polyomavirus SV40 is
incapable of infecting human kidney epithelium except in the presence of the GM1 ganglioside, recently reported to be an SV40
receptor.
D 2004 Elsevier Inc. All rights reserved.Keywords: BKV; SV40; Kidney; Proximal tubuleIntroduction
The process by which BKV infects its host, completes
an acute replication cycle, and then remains subclinical for
the lifetime of the host or becomes active upon immuno-
suppressive conditions is currently poorly understood.
Therefore, we wanted to develop a model system in which
BKV could be studied in vitro under conditions similar to
those it might encounter in vivo. Early studies on BKV
were performed using monkey-derived Vero cells, human
embryonic kidney cells, or human embryonic fibroblast
cells, which are not the normal target cells for the virus in
vivo (Maraldi et al., 1975; Seehafer et al., 1975). We have
chosen to characterize a BKV infection in human kidney
epithelial cells due to the known ability of BKV to infect
tubular epithelium in humans (Randhawa et al., 1999).
Human proximal tubule epithelial cells (HPTE cells) are
an important part of the kidney nephron. These cells0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: imperial@umich.edu (M. Imperiale).recover essential non-waste blood products and return
them to circulation, produce vitamin precursors, maintain
blood pressure and blood volume, and communicate with
the host immune system through the release of cytokines
when they sense infections or toxic molecules (Briggs et
al., 2001; Daha and van Kooten, 2000). A system has
been developed in which HPTE cells are able to maintain
their differentiated state in vitro and function in a renal
assist device. This device was developed to perform the
nutrient recovery, blood pressure, and blood volume func-
tions for patients with failing kidneys (Humes et al.,
2002). The HPTE cells used in the renal assist device
are capable of being passaged in culture up to six times.
Using these cells, we were able to observe viral protein
expression, DNA replication, and growth over the course
of infection of a known target cell type for BKV. We find
that BKV is capable of replicating efficiently and produc-
ing infectious virus particles within these cells. Interest-
ingly, SV40 cannot infect these cells except in the
presence of the GM1 ganglioside. The characterization of
BKV infection of HPTE cells sets the groundwork for
further studies to better understand how BKV is able to
persist within the human host and reactivate under immu-
nosuppressed conditions.
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We began these studies by asking whether BKV could
infect HPTE cells in vitro, and what the outcome of an
infection would be. We first examined expression of large T
antigen (TAg) as a marker for early gene expression. The
expression of TAg and its interaction with p53 and the
retinoblastoma family of tumor suppressors are critical for a
successful infection by polyomaviruses. We infected HPTE
cells with BKV at an MOI of 5 fluorescence forming units
(FFU)/cell, isolated total protein over the course of 11 days,
and assayed TAg expression by immunoblotting (Fig. 1A).
We first detected TAg expression between 12 and 24
h postinfection. Much higher levels of TAg expression were
detected between 24 and 36 h postinfection. The expression
of TAg peaked at 7 days postinfection, and remained high
throughout the rest of the time course.
The next step in the BKV life cycle is replication of its
DNA. To assess this step, we isolated low molecular weight
DNA from HPTE cells infected with BKVand digested with
EcoRI to linearize the BKV genome. We analyzed the
amount of viral DNA present by Southern blotting using
the BKV genome as a probe. We detected the presence of
low levels of viral DNA starting at 0 h postinfection (Fig.
1B). Due to the low and constant level of viral DNA seen
during the first 36 h of the infection, we believe that this is
DNA from input virus. The first increase in viral DNA
occurred at 36 h postinfection, which is expected due to the
onset of expression of TAg 12 h earlier. The level of viral
DNA increased throughout the course of infection, peaking
at 9 days postinfection. Metabolic labeling experiments
using tritiated thymidine confirmed that viral DNA synthe-
sis did not begin until 48 h postinfection (data not shown).
After determining when early viral proteins were
expressed and viral DNA was replicated, we went on to
establish when the major late viral protein VP1 was
expressed. Total cellular protein was isolated from HPTEFig. 1. Expression of BKV early and late proteins, and DNA replication. (A) Tot
analyzed as described in Materials and methods. (B) EcoRI-digested low molecul
probed for BKV sequences.cells infected with BKV over the course of 11 days.
Immunoblot analysis revealed the presence of VP1 at all
time points from 0 h postinfection to 11 days postinfection
(Fig. 1A). As was the case for viral DNA, the VP1 present at
0 h postinfection is probably from the input virus. The first
time that VP1 was expressed de novo was at 36 h postin-
fection, when there was a marked increase in its steady-state
levels. High levels of VP1 expression were seen 12 h later.
The amount of VP1 increased throughout the remainder of
the infection and was at its highest level when the time
course ended at 11 days postinfection.
When BKV infects a human kidney, it establishes a
subclinical infection unless the immune system has been
compromised. Under immunocompromised conditions or
immunosuppression, usually resulting from organ or bone
marrow transplantation, pregnancy, or HIV infection, high
levels of BKV replication are observed in the kidneys and
urinary tract, which can lead to hemorrhagic cystitis and
polyomavirus nephropathy (PVN) (Binet et al., 1999). Three
of the morphologic hallmarks of PVN are intranuclear viral
inclusions, focal necrosis of tubular cells, and cells rounding
up from the epithelial layer and extruding into the tubular
lumen (Nickeleit et al., 1999). We examined the morphology
of BKV-infected HPTE cells. As early as 4 days postinfec-
tion, we detected morphological characteristics in HPTE
cells that are also commonly observed in PVN. The HPTE
cells rounded up from the cell monolayer, likely due to cell
death, and contained enlarged nuclei and what appeared to be
inclusions (Fig. 2). These characteristics were more evident
at 9 days postinfection. Thus, BKV apparently undergoes a
lytic infection in HPTE cells, producing morphologic
changes similar to those seen in PVN.
The key event to which all other viral events lead is
progeny virus production. We determined the viral yield
over the course of an 11-day infection (Fig. 3). At 24
h postinfection, we detected the eclipse phase of infection,
when fewer mature virions were present. We then observedal cellular protein (25 Ag) isolated at the indicated times postinfection was
ar weight DNA was separated on an agarose gel, transferred to PVDF, and
Fig. 2. Morphology of BKV-infected HPTE cells. (A and B) HPTE cells were mock infected or infected with BKV at an MOI of 5 FFU/cell. Cells were fixed
and stained with hematoxylin at 4 days postinfection. (C) Kidney biopsy from a patient with PVN stained with hematoxylin. Arrows identify enlarged nuclei
and inclusion bodies in proximal tubule cells. Magnification is 400.
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days postinfection, concomitant with robust viral DNA and
late protein synthesis. After this early peak, the release of
progeny virus remained relatively constant for the remainder
of the infection.
We were also interested in whether SV40 can infect
HPTE cells. SV40 is the best studied of the polyomavirus
family and a close relative of BKV. An examination of
SV40 infection of human kidney cells is particularly inter-
esting because of accumulating evidence that SV40 infectsFig. 3. Growth of BKV in HPTE cells. Triplicate wells of HPTE cells were
infected with BKV at an MOI of 5 FFU/cell. Viral lysates were prepared at
the indicated days pi, and the titer determined. The mean and standard
deviation are shown.humans (Butel and Lednicky, 1999; Garcea and Imperiale,
2003). SV40 is known to infect proximal tubule cells in the
monkey kidney, causing a disease similar to that seen in
humans (Sheffield et al., 1980). Upon infecting HPTE cells
and BSC-1 cells, an established line of monkey kidney cells,
with SV40 we expected similar morphologies to those seen
in BKV-infected HPTE cells. However, at 11 days postin-
fection, cytopathic effects were evident in SV40-infected
BSC-1 cells, but not in HPTE cells. We looked for SV40
TAg as a marker of early protein expression. We detected
high levels of TAg expression in BSC-1 cells, but none at all
in HPTE cells, even at 13 days postinfection (Fig. 4A). To
determine if SV40 had entered the HPTE cells, we infected
HPTE and BSC-1 cells, extracted low molecular weight
DNA, and probed for the presence of SV40 DNA using a
Southern blot. In BSC-1 cells, the level of SV40 DNA
began to increase at 24 h postinfection, but in HPTE cells no
SV40 DNA was detected even at 4 days postinfection (Fig.
4B). These results suggest that SV40 is unable to infect
HPTE cells.
It has been reported that the cellular receptor for SV40 is
the major histocompatibility complex (MHC) class I mole-
cule (Atwood and Norkin, 1989). Immunoblotting of protein
lysates from the HPTE cells revealed that these cells express
this molecule at levels similar to human fibroblasts suscep-
tible to SV40 infection (data not shown). More recently,
however, Tsai et al. (2003) have reported that the ganglio-
side GM1 is required for entry of SV40 into mammalian
cells. We considered the possibility that a lack of GM1 on
the proximal tubule cells was the cause for the lack of
Fig. 4. SV40 infection of HPTE and BSC-1 cells. Cells were infected with SV40 at an MOI of 5 PFU/cell. Total cellular protein (25 Ag; A) or equal amounts of
DNA (B) isolated at the indicated days pi were analyzed as in Fig. 1, except that an SV40 probe was used for the Southern blot. (C) Cells were incubated with
the indicated ganglioside for 18 h before infection with BKVor SV40. Protein lysates were prepared at 0 and 96 h postinfection and analyzed as in Fig. 1A.
J. Low et al. / Virology 323 (2004) 182–188 185infectivity by SV40. HPTE cells were incubated with either
GM1 or GD1a, reported as a receptor for mouse polyoma-
virus (Py), and infected with SV40 or BKV (Tsai et al.,
2003). Immunoblots were used to detect the expression of
TAg. SV40 was able to infect HPTE cells preincubated with
GM1, confirming that the GM1 ganglioside is a receptor for
SV40 and indicating that the inability of SV40 to infect
HPTE cells is due to a lack of this ganglioside (Fig. 4C).
BKV was able to infect HPTE cells that had been preincu-
bated with either GM1 or GD1a, illustrating that GD1a does
not have an inhibitory effect on viral entry into these cells.Discussion
The experiments described in this paper define a system
in which BKV can be studied in vitro using a cell type that it
infects in vivo. While others have examined BKV infections
in cell culture, none of these previous studies have been
performed at a molecular level in a cell type infected in vivo
(Flaegstad and Traavik, 1987; Maraldi et al., 1975). We
have shown that BKV causes morphological changes in
vitro which are similar to those seen in BKV-induced
nephropathy in vivo and that a productive infection occurs.
While descriptive, the characterization of BKV infection ofthese cells is a critical first step to understanding how BKV
causes disease in the human host.
We first observed expression of high levels of TAg at 36
h postinfection. This 36-h delay from infection to expres-
sion of abundant TAg corresponds to work by others who
observed that in human fibroblasts, nuclear uncoating of
BKV occurs as late as between 24 and 30 h postinfection
(Maraldi et al., 1975). We also observed high levels of VP1
expression and DNA replication beginning at 48 h postin-
fection, 12 h after TAg was strongly expressed. Two days
after the components of the mature virion were first
synthesized, we observed a large peak in mature virion
production.
We do not have any indication that BKV can establish a
latent or persistent infection in tubular epithelial cells in
vitro. No cells survived the infection despite repeated
attempts to passage them. One major difference between
HPTE cells infected in vitro and in vivo is the lack of an
immune system. Therefore, our system reproduces what
likely occurs during a BKV infection in an immunosup-
pressed individual. Because BKV is reactivated upon im-
munosuppression, it is clear that the body keeps viral
replication in check without destroying the entire population
of infected cells. A component of the immune system
controlling BKV infection may be chemokines or cytokines.
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capable of inhibiting promoter activity of other viruses:
IFN-a inhibits murine CMV immediate early gene expres-
sion and IFN-g inhibits gene expression of constructs under
control of the human CMVor SV40 promoters (Gribaudo et
al., 1995; Harms and Splitter, 1995; Qin et al., 1997).
Further study is required to determine under which con-
ditions BKV gene expression and replication might be
repressed. The immune system may not be the only factor
playing a role in activation of BKV from its latent or
persistent state. In studies of Py, it has been reported that
mouse kidneys become permissive to lytic infection upon
cellular damage and subsequent tissue regeneration (Atencio
et al., 1993). It may be that a similar situation exists in the
transplant setting, in which BKV replication is stimulated
due to either ischemia or kidney damage during handling. It
is also possible that a change in hormone levels or stress
within an individual could cause the reactivation of BKV,
such as during pregnancy. PCR analysis of DNA isolated
from uninfected HPTE cells revealed that these cells did not
harbor any detectable BKV sequences before infection (data
not shown). Because it is known that BKV commonly
infects the proximal tubule in vivo, it may be slightly
surprising that we did not detect any viral sequences in
our cell lines. It is possible that during an in vivo infection,
only a few cells are infected, with this infection being kept
in check by the immune system and localized to certain
areas of the kidney (Chesters et al., 1983). Upon immuno-
suppression, the infection may become lytic and infect a
much larger population of kidney cells.
We have also demonstrated that SV40 does not infect
HPTE cells. Because SV40 infects tubular epithelial cells in
monkeys, (Sheffield et al., 1980) we expected that our
proximal tubule lines would be infected by SV40. The virus
apparently does not enter HPTE cells without the addition of
the GM1 ganglioside. It remains possible that in the absence
of GM1, SV40 is internalized into HPTE cells through a
different mechanism, but is unable to traffic to the nucleus
and begin lytic replication. Overexposures of our Southern
blots demonstrate the presence of input SV40 DNA in
HPTE infections in the absence of added gangliosides, but
we are unable to determine if the virus has been internalized
or remains on the cell surface. It is also possible that in
humans SV40 infects a different type of cell within the
kidney, retaining its organ tropism, or infects a different
tissue entirely. Two groups have reported the detection of
SV40 sequences in diseased human kidneys (Butel et al.,
1999; Li et al., 2002), so it is possible that SV40 can
lytically infect kidney cells under some circumstances.
Further study is required to determine why SV40 cannot
infect proximal tubule epithelium and which human cells, if
any, might act as reservoirs for the virus in vivo.
We have developed a system in which we can study lytic
BKV replication in phenotypically normal human kidney
epithelial cells. Given the prevalence of BKV in the human
population and its known associations with human disease,we believe that this system is an important first step towards
better understanding how BKV interacts with the host. We
are left with at least two major areas of study to pursue.
First, there are likely many cellular proteins and processes
that are influenced during infection. Second, we wish to
develop a model of BKV persistent infection and determine
what causes BKV to reactivate from its subclinical state.Materials and methods
Cell culture
Human kidney proximal tubule epithelial cells, isolated
from cadaveric tissue, were cultured as previously described
(Humes et al., 2002). The experiments described in this
report were performed on cells isolated from two separate
donors with no difference in the results.
Viruses
BKV stocks were initially propagated in 293 cells from
virus obtained from the American Type Culture Collection
(VR-837). Viral lysates were made through three cycles of
freezing the infected cells at 80 jC and thawing at 37 jC.
Once we determined that HPTE cells could be lytically
infected, one subsequent passage was performed on HPTE
cells. The regulatory region of these stocks, as determined
by sequencing of PCR products, was identical to the TU
strain (Sundsfjord et al., 1990). For the SV40 studies we
used strain 776.
Viral titers
Viral titer was determined using a fluorescent focus
assay, rather than hemagglutination inhibition, due to its
ability to detect infectious virus. Seventy percent confluent
HPTE cells in 12-well dishes were infected with 10-fold
dilutions of BKV for 4 days at 37 jC. The cells were fixed
for 30 min using 70% ethanol/30% PBS (Liu and Atwood,
2001) PAb416 (Harlow et al., 1981) followed by a fluores-
cein-conjugated anti-mouse antibody (Sigma) used to detect
TAg. Titer, measured in fluorescence forming units (FFU),
was determined by counting five random fields. The titer of
SV40 was determined on BSC-1 monolayers by the agar
overlay method (Brockman et al., 1973).
Infections
Cells were grown in 6-well dishes to 70% confluence,
and infected with BKVor SV40 at an MOI of 5 FFU/cell. To
stain with hematoxylin (Gill III formula), cells were fixed in
4% paraformaldehyde, washed with PBS, and rehydrated
with ethanol. For infections to which gangliosides were
added, cells were preincubated with either media, 3.2 AM
GM1, or 2.7 AM GD1a (gift of B. Tsai) for 18 h at 37 jC,
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al., 2003).
Immunoblotting
Total cell protein was extracted using E1A lysis buffer
(Harlow et al., 1986) containing 0.05 M NaF and Complete
EDTA-free protein inhibitors (Roche). Protein concentration
was determined using the Bio-Rad protein assay, and equal
amounts of protein were electrophoresed on an 8% SDS–
polyacrylamide gel. PAb416 was used to detect TAg ex-
pression, P5G6 (gift of D. Galloway) for VP1 expression,
and GAPDH Ab8245 (Abcam) for glyceraldehyde-3-phos-
phate-dehydrogenase expression. After washing, blots were
probed with a horseradish peroxidase-conjugated secondary
antibody (Sigma). Antibody complexes were detected using
ECL+ reagent (Amersham) and exposure to film.
DNA replication assays
Low molecular weight DNA was isolated from infected
cells using the protocol described by Hirt (1967). One
quarter of the DNA isolated from each sample was digested
with EcoRI, electrophoresed, and transferred to a PVDF
membrane. A random-labeled probe was synthesized from a
plasmid containing either the BKV or SV40 genome. The
probe was allowed to hybridize for 16 h at 65 jC, after which
the membrane was washed twice with 2 SSC and once with
2 SSC and 1%. The membrane was then exposed to film.
Virus growth assay
Viral lysates, prepared by three freeze–thaw cycles as
described above (Knowles, 2001), were collected in tripli-
cate from HPTE cells infected with BKV at an MOI of 5
FFU/cell. The viral lysates were prepared by three freeze–
thaw cycles as described above. The titer of the virus in
these lysates was determined using the fluorescent focus
assay described above.Acknowledgments
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